Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
04/2003
04/02/2003EP1297111A2 A novel helicase family member and uses therefor
04/02/2003EP1297016A2 Use of inhibitors of placental growth factor for the treatment of pathological angiogenesis, pathological arteriogenesis, inflammation, tumour formation and/or vascular leakage
04/02/2003EP1297014A2 Transporters and ion channels
04/02/2003EP1297013A2 Use of taci as an anti-tumor agent
04/02/2003EP1297012A2 Novel fibroblast growth factors and nucleic acids encoding same
04/02/2003EP1297011A1 The t-cell protein tzon7, peptides and antibodies derived therefrom and uses thereof
04/02/2003EP1297008A2 Cerebellin homologous polypeptides and therapeutic uses thereof
04/02/2003EP1297007A2 Mammalian protein phosphatases
04/02/2003EP1297006A2 Regulation of human prostasin-like serine protease
04/02/2003EP1297005A2 Immunisation against chlamydia pneumoniae
04/02/2003EP1297002A2 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery
04/02/2003EP1297001A1 Amphipathic linear peptides and compositions containing same
04/02/2003EP1297000A2 Peptides mimicking the biological activity of steroid hormones and their uses
04/02/2003EP1296999A2 Neuroactive peptides for treatment of hypoxia and related conditions
04/02/2003EP1296948A2 Novel gamma crystalline form of perindopril tert-butylamine salt, preparation method, and pharmaceutical compositions containing same.
04/02/2003EP1296947A1 $g(A) CRYSTALLINE FORM OF PERINDOPRIL TERT-BUTYLAMINE SALT
04/02/2003EP1296742A1 Needle for intradermal delivery of substances having penetration limiting means
04/02/2003EP1296740A1 Microneedle for delivering a substance into the dermis
04/02/2003EP1296723A1 A medicinal aerosol formulation
04/02/2003EP1296720A2 Poliovirus replicons encoding therapeutic agents and uses thereof
04/02/2003EP1296718A1 Pharmaceutical composition of modified pna molecules
04/02/2003EP1296713A1 Immunostimulatory oligodeoxynucleotides
04/02/2003EP1296712A2 Hiv-1 vaccines and screening methods therefor
04/02/2003EP1296711A2 Human papilloma virus treatment
04/02/2003EP1296708A1 Use of secretin-receptor ligands in treatment of cystic fibrosis (cf) and chronic obstructive pulmonary disease (copd)
04/02/2003EP1296707A1 Methods of treating viral diseases with il-18 and il-18 combinations
04/02/2003EP1296706A1 Osteoclast secreted chemokine and uses thereof
04/02/2003EP1296705A1 Neurotoxic oligomers
04/02/2003EP1296704A2 Peptides with physiological activity
04/02/2003EP1296702A1 Neuroprotective peptides
04/02/2003EP1296690A2 METHOD FOR THE TREATMENT OR PREVENTION OF i FLAVIVIRUS /i INFECTIONS USING NUCLEOSIDE ANALOGUES
04/02/2003EP1296678A2 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy
04/02/2003EP1296676A1 Use of indole-3-acetic acid derivatives in medicine
04/02/2003EP1296666A2 Improved thyroid hormone formulations
04/02/2003EP1296660A1 The controlled release preparation of insulin and its method
04/02/2003EP1296655A1 Endoparasiticidal agents for voluntary oral ingestion by animals
04/02/2003EP1296648A1 Micellar pharmaceutical compositions for buccal and pulmonary application
04/02/2003EP1296636A1 USE OF EXOGENOUS LACTIC BACTERIA STRAIN AGAINST i ACTINOMYCES NAESLUNDII /i RELATED DISEASES
04/02/2003EP1296590A2 A personal condition management system
04/02/2003EP1296554A2 Prevention and treatment of mycoplasma-associated diseases
04/02/2003EP1296552A2 Erk-5 deficient animals and methods of inhibiting angiogenesis through the inhibition of erk-5
04/02/2003EP1212312B1 Novel derivatives of flavones, xanthones and coumarins
04/02/2003EP1191999B1 Method of particle formation
04/02/2003EP1171451A4 Separation of plasma components
04/02/2003EP1131091B1 Treatment of viral hemorrhagic fever with protein c
04/02/2003EP1092038A4 OCT1p, A PROTEIN HAVING HOMOLOGY TO THE ORGANIC AND SUGAR TRANSPORTER FAMILY OF PROTEINS, AND USES THEREOF
04/02/2003EP0954519B1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
04/02/2003EP0928335B1 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES
04/02/2003EP0923592B1 Methods for purifying nucleic acids
04/02/2003EP0914460B1 Vehicle for the transport of molecular substances
04/02/2003EP0885189B9 Method for the synthesis of poly-pyrrole and poly-imidazole carboxamides on a solid support
04/02/2003EP0873295B1 Dimer-selective rxr modulators and methods for their use
04/02/2003EP0871464B1 Bradykinin analogs as selective thrombin inhibitors
04/02/2003EP0828481B1 Oral dosage composition comprising zonula occludens toxin and a biologically active ingredient and use thereof
04/02/2003EP0804283B1 Aqueous solvent encapsulation method and microcapsules
04/02/2003EP0804236B1 Use of anti-tnf antibodies as drugs in treating diseases involving elevated interleukin-6 serum levels
04/02/2003EP0702518B1 Treatment of vascular degenerative diseases by modulation of endogenous nitric oxide production or activity
04/02/2003EP0700444B1 Immunotoxins comprising gelonin and an antibody
04/02/2003EP0696326B1 Use of NDV in the manufacture of a medicament for treating cancer
04/02/2003EP0644772B1 Opioid peptides
04/02/2003EP0623169B1 Hepatitis e virus vaccine and method
04/02/2003EP0610446B1 Synthetic peptide specificity of anti-myelin basic protein from multiple sclerosis cerebrospinal fluid
04/02/2003EP0610427B1 Tgf-beta type iii receptor, cdna encoding it and uses therefor
04/02/2003EP0566732B1 Adeno-associated virus-2 basal vectors
04/02/2003CN1408022A Recombinant adenoviruses for sodium/iodide symporter (NIS)
04/02/2003CN1407992A Process for producing functional silk fibroin and utilization of the same
04/02/2003CN1407989A Antithrombotic compound
04/02/2003CN1407972A 4-pyrimidine-N-acyl-L-phenylalanines
04/02/2003CN1407900A Methods of treating or preventing cell, tissue, and organ damage using human myeloid progenitor inhibitory factor-1 (MPIF-1)
04/02/2003CN1407899A Pharmaceutical combination for treatment of tissue damage owing to arterial irrigation defect
04/02/2003CN1407102A Polypeptide-aconitase-10.57 and polynucleotide for encoding it
04/02/2003CN1407101A Polypeptide-aconitase-10.56 and polynucleotide for encoding it
04/02/2003CN1407099A Polypeptide-N-acetylglucosamine-1-phosphodiester-N-acelylglucosaccharaase-15.84 and polynucleotide for encoding it
04/02/2003CN1407098A Polypeptide-lipase-9.57 and polynucleotide for encoding it
04/02/2003CN1407097A Polypeptide-lipase-11.55 and polynucleotide for encoding it
04/02/2003CN1407096A Polypeptide-ATP ase-36.41 relating to DNA repair and polynucleotide for encoding it
04/02/2003CN1407095A Polypeptide-fructose-1,6-diphosphatase-16.61 and polynucleotide for encoding it
04/02/2003CN1407094A Polypeptide-despiral enzyme-95.48 and polynucleotide for encoding it
04/02/2003CN1407093A Selenium Nadou enzyme and preparing process thereof
04/02/2003CN1407092A Polypeptide-UDPG-galactoside ceramide glucose aldehyde group collagen transferase-10.89 and polynucleotide for encoding it
04/02/2003CN1407091A Polypeptide-human sterculic acid dehydrase-56.98 and polynucleotide for encoding it
04/02/2003CN1407090A Polypeptide human acyl coenzyme A dehydrase-74.47 and polynucleotide for encoding it
04/02/2003CN1407089A Polypeptide-gammal-pyrroline-5-hydroxy-reductase 49.17 and polynucleotide for encoding it
04/02/2003CN1407085A Modular automatic production line for biopharmaceutics
04/02/2003CN1406950A Human lung cancer antigen and its antibody
04/02/2003CN1406948A Peptide as VEGF receptor KDR antagonist
04/02/2003CN1406947A Short peptide and its derivative and medicine with them as active component and use thereof
04/02/2003CN1406633A Scarless composite biological material containing hyaluronic acid
04/02/2003CN1406631A Establishment of drug production system by non-virus bio-technology
04/02/2003CN1406630A Composite enzyme reacting liquid
04/02/2003CN1406629A Vaccin of heterogenous blood vessel endothetial cell growth factor and preparing process thereof
04/02/2003CN1406628A Hemostatics powder and preparation thereof
04/02/2003CN1406614A Method for preparing patent Chinese medicines by biological technology
04/02/2003CN1104501C Modified human C3 proteins
04/02/2003CN1104440C Method for variation of chromatin condensation
04/02/2003CN1104257C Oesteoblast growth stimulating composition containing PDGF and vitamin D
04/02/2003CN1104256C Cyclosporin soft capsule composition
04/02/2003CN1104241C Use of 1-(2-naphth-2-ylethyl)-4-(3-trifluoromethylphenyl)-1,2,3,6-tetraphdropyridine for preparing drugs for treating amyotrophic lateral scherosis
04/02/2003CN1104238C Enteric-coated pharmaceutical compositions of mycophenolate
04/02/2003CN1104202C Aglucone isoflavone enriched vegetable protein extract and isolate and process for producing
1 ... 1875 1876 1877 1878 1879 1880 1881 1882 1883 1884 1885 1886 1887 1888 1889 1890 1891 1892 1893 1894 1895 ... 3163